Ausgabe 12/2023
Inhalt (21 Artikel)
Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing
Pablo Corral, Carlos A. Aguilar Salinas, María Gabriela Matta, Valeria Zago, Laura Schreier
Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy
Jelani K. Grant, Carl E. Orringer
How to Handle Elevated Triglycerides: Life after PROMINENT
Angela Pirillo, Alberico L. Catapano
Rap1 in the Context of PCSK9, Atherosclerosis, and Diabetes
Heena Agarwal, Brea Tinsley, Amesh K. Sarecha, Lale Ozcan
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
Natalie Arnold, Wolfgang Koenig
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?
Hana Poloczková, Jan Krejčí
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress
Kartik Gupta, Colin Hinkamp, Tyler Andrews, Chelsea Meloche, Abdul Mannan Khan Minhas, Leandro Slipczuk, Elizabeth Vaughan, Fatima Zohra Habib, Sana Sheikh, Dinesh Kalra, Salim S. Virani
Natural Sirtuin1 Activators and Atherosclerosis: an Overview
Karolina Łanoszka, Nimasha Vlčková
Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease
Yulith Roca Alvarez, Madison Pico, Namrita Ashokprabhu, Kareem Abou-Amro, Samantha Bailey, Elizabeth Pung, Evan Oberholster, Odayme Quesada
Gene Regulatory Networks in Coronary Artery Disease
Jenny Cheng, Michael Cheng, Aldons J. Lusis, Xia Yang
Caregiver Influences on Eating Behaviors in Children: An Opportunity for Preventing Obesity
Lorraine M. Schratz, Olivia Larkin, Nilse Dos Santos, Christine Martin
Emerging Preventive Strategies in Chronic Kidney Disease: Recent Evidence and Gaps in Knowledge
Nishigandha Pradhan, Mirela Dobre
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management
Zulqarnain Javed, Harun Kundi, Ryan Chang, Anoop Titus, Hassaan Arshad
Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches
Nitesh Gautam, Joshua Mueller, Omar Alqaisi, Tanmay Gandhi, Abdallah Malkawi, Tushar Tarun, Hani J. Alturkmani, Muhammed Ali Zulqarnain, Gianluca Pontone, Subhi J. Al’Aref
Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?
Steve E Humphries, Uma Ramaswami, Neil Hopper
HDL as a Treatment Target: Should We Abandon This Idea?
Floran Begue, Marie Laurine Apalama, Gilles Lambert, Olivier Meilhac
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia
Miriam Larouche, Etienne Khoury, Diane Brisson, Daniel Gaudet
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity
Krunal Amin, Garrett Bethel, Larry R. Jackson II, Utibe R. Essien, Caroline E. Sloan